Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 1,648.00
-1.80 (-0.11%)
May 11, 2026, 3:30 PM IST
Dr. Lal PathLabs Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 27,629 | 24,614 | 22,266 | 20,169 | 20,874 | |
Revenue Growth (YoY) | 12.25% | 10.54% | 10.40% | -3.38% | 32.01% |
Cost of Revenue | 10,379 | 10,373 | 9,476 | 8,920 | 9,198 |
Gross Profit | 17,250 | 14,241 | 12,790 | 11,249 | 11,676 |
Selling, General & Admin | 4,024 | 4,501 | 4,135 | 3,577 | 3,474 |
Other Operating Expenses | 5,401 | 2,717 | 2,528 | 2,769 | 2,569 |
Operating Expenses | 11,043 | 8,648 | 8,109 | 7,848 | 7,129 |
Operating Income | 6,207 | 5,593 | 4,681 | 3,402 | 4,547 |
Interest Expense | -228 | -223.05 | -293.59 | -375.3 | -301.71 |
Interest & Investment Income | - | 664.58 | 554.3 | 331.78 | 472.61 |
Other Non Operating Income (Expenses) | 1,013 | 22.35 | 1.24 | 1.02 | 1.27 |
EBT Excluding Unusual Items | 6,992 | 6,057 | 4,943 | 3,359 | 4,719 |
Gain (Loss) on Sale of Investments | - | 209.3 | 103.97 | 64.21 | 31.62 |
Gain (Loss) on Sale of Assets | - | -21.51 | -2.18 | 8.07 | -6 |
Other Unusual Items | -301 | 3.35 | 9.29 | 6.96 | 4.95 |
Pretax Income | 6,691 | 6,248 | 5,055 | 3,438 | 4,750 |
Income Tax Expense | 1,593 | 1,325 | 1,432 | 1,028 | 1,247 |
Earnings From Continuing Operations | 5,098 | 4,923 | 3,623 | 2,411 | 3,503 |
Minority Interest in Earnings | -50 | -51.14 | -45.58 | -22.29 | -54.58 |
Net Income | 5,048 | 4,871 | 3,577 | 2,388 | 3,448 |
Net Income to Common | 5,048 | 4,871 | 3,577 | 2,388 | 3,448 |
Net Income Growth | 3.63% | 36.17% | 49.78% | -30.73% | 18.25% |
Shares Outstanding (Basic) | 167 | 167 | 166 | 166 | 165 |
Shares Outstanding (Diluted) | 167 | 167 | 166 | 166 | 166 |
Shares Change (YoY) | 0.19% | 0.22% | 0.14% | 0.21% | 0.24% |
EPS (Basic) | 30.24 | 29.24 | 21.52 | 14.41 | 20.85 |
EPS (Diluted) | 30.20 | 29.20 | 21.49 | 14.37 | 20.79 |
EPS Growth | 3.43% | 35.88% | 49.55% | -30.86% | 17.93% |
Free Cash Flow | 4,687 | 5,246 | 4,842 | 4,195 | 3,526 |
Free Cash Flow Per Share | 28.04 | 31.44 | 29.08 | 25.24 | 21.25 |
Dividend Per Share | 14.000 | 12.000 | 12.000 | 6.000 | 6.000 |
Dividend Growth | 16.67% | - | 100.00% | - | -40.00% |
Gross Margin | 62.43% | 57.86% | 57.44% | 55.77% | 55.94% |
Operating Margin | 22.47% | 22.72% | 21.02% | 16.86% | 21.78% |
Profit Margin | 18.27% | 19.79% | 16.07% | 11.84% | 16.52% |
Free Cash Flow Margin | 16.96% | 21.31% | 21.74% | 20.80% | 16.89% |
EBITDA | 7,825 | 6,579 | 5,673 | 4,412 | 5,188 |
EBITDA Margin | 28.32% | 26.73% | 25.48% | 21.88% | 24.86% |
D&A For EBITDA | 1,618 | 986.35 | 991.13 | 1,011 | 641.4 |
EBIT | 6,207 | 5,593 | 4,681 | 3,402 | 4,547 |
EBIT Margin | 22.47% | 22.72% | 21.02% | 16.86% | 21.78% |
Effective Tax Rate | 23.81% | 21.21% | 28.32% | 29.88% | 26.25% |
Revenue as Reported | 28,642 | 25,548 | 22,958 | 20,586 | 21,400 |
Advertising Expenses | - | 778.41 | 733.49 | 507.8 | 367.64 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.